...
首页> 外文期刊>Current medical research and opinion >Time to significant pain reduction following DETP application vs placebo for acute soft tissue injuries.
【24h】

Time to significant pain reduction following DETP application vs placebo for acute soft tissue injuries.

机译:与安慰剂相比,应用DETP后可明显减轻疼痛,可治疗急性软组织损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Nonsteroidal anti-inflammatory drugs (NSAIDs) provide fast and effective acute pain relief, but systemic administration has increased risk for some adverse reactions. The diclofenac epolamine 1.3% topical patch (DETP) is a topical NSAID with demonstrated safety and efficacy in treatment of acute pain from minor soft tissue injuries. Significant pain reduction has been observed in clinical trials within several hours following DETP application, suggesting rapid pain relief; however, this has not been extensively studied for topical NSAIDs in general. This retrospective post-hoc analysis examined time to onset of significant pain reduction after DETP application compared to a placebo patch for patients with mild-to-moderate acute ankle sprain, evaluating the primary efficacy endpoint from two nearly identical studies. RESEARCH DESIGN AND METHODS: Data from two double-blind, randomized, parallel-group, placebo-controlled studies (N = 274) of safety and efficacy of the DETP applied once daily for 7 days for acute ankle sprain were evaluated post-hoc using statistical modeling to estimate time to onset of significant pain reduction following DETP application. MAIN OUTCOME MEASURES: Pain on active movement on a 100 mm Visual Analog Scale (VAS) recorded in patient diaries; physician- and patient-assessed tolerability; and adverse events. RESULTS: DETP treatment resulted in significant pain reduction within approximately 3 hours compared to placebo. Within-treatment post-hoc analysis based on a statistical model suggested significant pain reduction occurred as early as 1.27 hours for the DETP group. The study may have been limited by the retrospective nature of the analyses. In both studies, the DETP was well tolerated with few adverse events, limited primarily to application site skin reactions. CONCLUSION: The DETP is an effective treatment for acute minor soft tissue injury, providing pain relief as rapidly as 1.27 hours post-treatment. Statistical modeling may be useful in estimating time to onset of pain relief for comparison of topical and oral NSAIDs.
机译:目的:非甾体类抗炎药(NSAIDs)可以快速有效地缓解急性疼痛,但是全身给药增加了某些不良反应的风险。双氯芬酸依泊明1.3%局部贴剂(DETP)是一种局部NSAID,在治疗轻度软组织损伤引起的急性疼痛方面具有安全性和有效性。在应用DETP后数小时内,在临床试验中已观察到疼痛明显减轻,表明疼痛迅速缓解。但是,一般来说,尚未对局部用药进行广泛研究。这项回顾性事后分析检查了DETP施用后与安慰剂贴剂相比在轻度至中度急性踝扭伤患者中显着减轻疼痛发作的时间,评估了两项几乎相同的研究的主要疗效终点。研究设计和方法:每天两次使用DETP进行7天急性踝扭伤的安全性和有效性的两项双盲,随机,平行组,安慰剂对照研究(N = 274)的数据在事后进行评估,方法如下:统计模型可估计DETP应用后疼痛明显减轻的发作时间。主要观察指标:患者日记中记录的100毫米视觉模拟量表(VAS)上的主动运动疼痛;由医生和患者评估的耐受性;和不良事件。结果:与安慰剂相比,DETP治疗可在约3小时内显着减轻疼痛。根据统计模型进行的治疗后事后分析表明,DETP组早在1.27小时就可明显减轻疼痛。这项研究可能受分析的回顾性限制。在两项研究中,对DETP的耐受性都很好,几乎没有不良事件,主要限于应用部位的皮肤反应。结论:DETP是急性轻度软组织损伤的有效治疗方法,可在治疗后1.27小时迅速缓解疼痛。统计模型可用于估计疼痛缓解发作的时间,以比较局部和口服NSAID。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号